Pharma Conversation & Community

Pharmaceutical Technology, Pharmaceutical Technology-01-02-2013, Volume 37, Issue 1

A round up of news from across the web, including trends from social social media platforms.


FDA Issues Draft Guidance on Electronic Submissions

FDA has issued a draft guidance, Guidance for Industry: Providing Submissions in Electronic Format—Summary Level Clinical Site Data for CDER's Inspection Planning, which is one in a series of documents intended to assist sponsors and applicants making certain regulatory submissions to FDA in electronic format.

US Supreme Court to Hear Pay-for-Delay Case

The US Supreme Court agreed to hear a case that will decide whether brand-name drug companies may pay generic drug-companies to delay introduction of lower-cost generic drugs. The Supreme Court is to review a federal appeals court ruling that upheld a "pay-for-delay" arrangement.

Ranbaxy Recalls Atorvastatin Due to Quality Issues

Ranbaxy Pharmaceuticals is recalling certain lots of its atorvastatin tablets because of possible contamination with small glass particles (less than 1 mm in size). Ranbaxy has ceased atorvastatin manufacturing until it has thoroughly investigated the problem.


  • Valeant Pharmaceuticals International has completed its acquisition of Medicis Pharmaceutical.

  • Isochem has expanded its range of intermediates by acquiring the British fine-chemicals company, Wychem.

  • French contract manufacturing firm Synerlab has acquired lyophilization specialist company Lyofal.

  • Amgen has agreed to buy Icelandic-based Decode Genetics for $415 million in an all-cash transaction.


PharmTech is seeking reader input for a future feature on parenteral drug manufacturing. Send your questions and thoughts to the Community Manager, Stephanie Sutton, at


Take part in our latest poll at:


"Real-time devices for continuous feeding processes were discussed at a seminar I recently attended."

Jennifer Markarian,

See more posts at


  • Pharma companies using new analytical methods to ensure quality of medicine

  • How to optimize continuous processing and make it work in pharmaceutical manufacturing is a crucial issue.